Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway

• Main Authors: Hiromasa Kato (Author), Hiroshi Watanabe (Author), Tadashi Imafuku (Author), Nanaka Arimura (Author), Issei Fujita (Author), Isamu Noguchi (Author), Shoma Tanaka (Author), Takehiro Nakano (Author), Kai Tokumaru (Author), Yuki Enoki (Author), Hitoshi Maeda (Author), Shinjiro Hino (Author), Motoko Tanaka (Author), Kazutaka Matsushita (Author), Masafumi Fukagawa (Author), Toru Maruyama (Author)
• Format: Book
• Published: Wiley, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Sarcopenia with chronic kidney disease (CKD) progression is associated with life prognosis. Oxidative stress has attracted interest as a trigger for causing CKD‐related muscular atrophy. Advanced oxidation protein products (AOPPs), a uraemic toxin, are known to increase oxidative...